Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
9.09 USD | +0.11% | -1.73% | +39.85% |
Apr. 30 | RBC Lifts Price Target on Avid Bioservices to $8 From $7, Keeps Outperform Rating | MT |
Apr. 29 | Transcript : Avid Bioservices, Inc., Q3 2024 Earnings Call, Apr 29, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+39.85% | 577M | |
-1.62% | 89.22B | |
+2.24% | 40.49B | |
-12.97% | 32.79B | |
+63.56% | 26.23B | |
-20.71% | 14.52B | |
-7.31% | 13.09B | |
-12.64% | 11.5B | |
-42.60% | 11.6B | |
+5.32% | 8.82B |
- Stock Market
- Equities
- CDMO Stock
- News Avid Bioservices, Inc.
- Craig-Hallum Adjusts Avid Bioservices' Price Target to $16 From $22, Maintains Buy Rating